Heart Failure
CLEAR SYNERGY is the largest trial to date on colchicine treatment in myocardial infarction.
The CardioNerds and Dr. Minnow Walsh discuss Dr. Walsh's personal and professional journey in cardiology.
Researchers have developed a novel blood test that can diagnose a heart attack within minutes.
COVID-19 infection may increase the risk of heart attack, stroke and all-cause mortality up to three years post-infection.
BridgeBio Pharma announced this week outcomes from the ATTRibute-CM study will be shared at AHA 2024.
Bridge Bio Pharma presented results from a post-hoc analysis which demonstrated the efficacy of acoramidis in ATTR-CM.
Advertisement
Expert Interviews on Heart Failure
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.